High-Density Lithium Niobate Photonic Integrated Circuits
HDLN aims to develop high-density thin-film lithium niobate technology for compact, low-voltage electro-optic modulators to enhance photonic integration for ultra-fast communications.
Projectdetails
Introduction
Translating high-speed electrical signals to the optical domain, electro-optic (EO) modulators are key components of photonic systems. On a technological level, lithium niobate (LN) has become a mainstay for such devices, offering a unique combination of strong EO activity and chemical stability as well as wide-band transparency and the ability to withstand high optical power levels.
Recent Advances
Recent advances in thin-film LN have opened an attractive path towards:
- Compact footprint
- Low operation voltage
- Large bandwidth
These advancements maintain the intrinsic advantages of the underlying material system. However, there is still a need to further reduce the component size and increase the component density of LN circuits to truly enable large-scale photonic integration in volume over the current wafer sizes, which are still far from the 200-300 mm scale of silicon photonics.
Project Goals
It is thus the goal of HDLN to establish an internationally unique technology base related to high-density thin-film LN technology. HDLN will demonstrate the viability of the technology platform through a series of demonstrators, geared towards highly relevant applications such as:
- Ultra-fast optical communications
- Ultra-wideband photonic-electronic signal processing
Collaboration
HDLN brings together a careful selection of experienced partners from academia and industry, comprising:
- A recently incorporated start-up for the manufacturing platform
- An independent photonic design and test house
- An internationally leading company in the field of communications that validates the technology at the application level.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.549.111 |
Totale projectbegroting | € 1.549.111 |
Tijdlijn
Startdatum | 1-5-2023 |
Einddatum | 31-10-2025 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- VLC PHOTONICS SLpenvoerder
- NOKIA NETWORKS FRANCE
- KARLSRUHER INSTITUT FUER TECHNOLOGIE
- ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
- LUXTELLIGENCE SA
Land(en)
Vergelijkbare projecten binnen EIC Transition
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Targeting cardiac fibrosis with next generation RNA therapeuticsFIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness. | EIC Transition | € 2.499.482 | 2022 | Details |
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationSThe NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring. | EIC Transition | € 2.497.750 | 2022 | Details |
Predictive REagent-Antibody Replacement Technology stage 2-TranslationPRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment. | EIC Transition | € 800.000 | 2022 | Details |
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stageDeveloping a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships. | EIC Transition | € 2.499.810 | 2022 | Details |
Targeting cardiac fibrosis with next generation RNA therapeutics
FIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness.
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS
The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.
Predictive REagent-Antibody Replacement Technology stage 2-Translation
PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage
Developing a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Lithium Niobate Quantum systemsThis project aims to develop integrated Lithium Niobate Quantum systems (LiNQs) to create a comprehensive platform for scalable quantum photonic circuits, enhancing Europe's quantum technology capabilities. | ERC STG | € 2.499.381 | 2022 | Details |
LIQuid-crystal enabled Universal Optical Reconfigurable Integrated Circuit EngineeringLIQUORICE aims to develop a programmable photonic processor for rapid prototyping in diverse applications, enhancing innovation and measurement capabilities in photonics technology. | ERC POC | € 150.000 | 2022 | Details |
High Speed Communication Links Based on Heterogeneous ChipsThe COMb project aims to develop ultra-high-speed transceivers using Indium Phosphide and Lithium Niobate on a silicon nitride platform to enhance data transmission rates and efficiency. | ERC POC | € 150.000 | 2022 | Details |
3D integrated photonic nanostructures with Giant optical nonlinearity3DnanoGiant aims to develop innovative nonlinear photonic materials using liquid crystals for efficient all-optical signal processing in integrated photonic devices. | ERC STG | € 1.500.000 | 2025 | Details |
Lithium Niobate Quantum systems
This project aims to develop integrated Lithium Niobate Quantum systems (LiNQs) to create a comprehensive platform for scalable quantum photonic circuits, enhancing Europe's quantum technology capabilities.
LIQuid-crystal enabled Universal Optical Reconfigurable Integrated Circuit Engineering
LIQUORICE aims to develop a programmable photonic processor for rapid prototyping in diverse applications, enhancing innovation and measurement capabilities in photonics technology.
High Speed Communication Links Based on Heterogeneous Chips
The COMb project aims to develop ultra-high-speed transceivers using Indium Phosphide and Lithium Niobate on a silicon nitride platform to enhance data transmission rates and efficiency.
3D integrated photonic nanostructures with Giant optical nonlinearity
3DnanoGiant aims to develop innovative nonlinear photonic materials using liquid crystals for efficient all-optical signal processing in integrated photonic devices.